Hester Biosciences Limited (NSE:HESTERBIO)
1,419.40
+53.80 (3.94%)
Apr 2, 2026, 3:29 PM IST
Hester Biosciences Employees
Hester Biosciences had 562 employees as of March 31, 2025. The number of employees decreased by 80 or -12.46% compared to the previous year.
Employees
562
Change (1Y)
-80
Growth (1Y)
-12.46%
Revenue / Employee
5.62M INR
Profits / Employee
728.59K INR
Market Cap
12.15B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 562 | -80 | -12.46% |
| Mar 31, 2024 | 642 | -51 | -7.36% |
| Mar 31, 2023 | 693 | 109 | 18.66% |
| Mar 31, 2022 | 584 | 156 | 36.45% |
| Mar 31, 2021 | 428 | 31 | 7.81% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Solara Active Pharma Sciences | 1,775 |
| Sigachi Industries | 1,507 |
| Jagsonpal Pharmaceuticals | 1,399 |
| Windlas Biotech | 1,346 |
| RPG Life Sciences | 1,331 |
| Ind-Swift Laboratories | 1,246 |
| Orchid Pharma | 736 |
Hester Biosciences News
- 2 months ago - Hester Biosciences Ltd (BOM:524669) Q3 2026 Earnings Call Highlights: Strong Poultry Growth and ... - GuruFocus
- 2 months ago - Q3 2026 Hester Biosciences Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Hester Biosciences Q3 PAT jumps 140% to Rs 10.67cr - The Times of India
- 8 months ago - Q1 2026 Hester Biosciences Ltd Earnings Call Transcript - GuruFocus
- 8 months ago - Hester Biosciences shares rally 15% as Q1 profit soars 131% YoY to Rs 17.3 crore, revenue rises 2% - Business Upturn
- 1 year ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 1 year ago - Hester Biosciences shares surge over 11% following strong Q2 FY25 performance - Business Upturn
- 1 year ago - Hester Biosciences Q2: Revenue jumps 18.8% YoY to ₹83.69 crores, PAT surges 107.4% YoY to ₹8.39 crores - Business Upturn